Danish Start-Up ADCendo Takes Aim At Novel Cancer Target With Fresh Funds

Fully Funded Biotech Plans Proof-Of-Concept In Man by End-2025

May 19 2021

• By Sten Stovall

uPARAP is overexpressed on the cell surface of several cancers • Source: Alamy

More from Emerging Company Profiles

More from Start-Ups & SMEs